These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 17113035

  • 1. Solid-phase classical complement activation by C-reactive protein (CRP) is inhibited by fluid-phase CRP-C1q interaction.
    Sjöwall C, Wetterö J, Bengtsson T, Askendal A, Almroth G, Skogh T, Tengvall P.
    Biochem Biophys Res Commun; 2007 Jan 05; 352(1):251-8. PubMed ID: 17113035
    [Abstract] [Full Text] [Related]

  • 2. Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q.
    Jiang HX, Siegel JN, Gewurz H.
    J Immunol; 1991 Apr 01; 146(7):2324-30. PubMed ID: 2005402
    [Abstract] [Full Text] [Related]

  • 3. Defined chemically cross-linked oligomers of human C-reactive protein: characterization and reactivity with the complement system.
    Jiang H, Lint TF, Gewurz H.
    Immunology; 1991 Dec 01; 74(4):725-31. PubMed ID: 1783430
    [Abstract] [Full Text] [Related]

  • 4. Effect of modified C-reactive protein on complement activation: a possible complement regulatory role of modified or monomeric C-reactive protein in atherosclerotic lesions.
    Ji SR, Wu Y, Potempa LA, Liang YH, Zhao J.
    Arterioscler Thromb Vasc Biol; 2006 Apr 01; 26(4):935-41. PubMed ID: 16456095
    [Abstract] [Full Text] [Related]

  • 5. Studies on the interactions between C-reactive protein and complement proteins.
    Bíró A, Rovó Z, Papp D, Cervenak L, Varga L, Füst G, Thielens NM, Arlaud GJ, Prohászka Z.
    Immunology; 2007 May 01; 121(1):40-50. PubMed ID: 17244159
    [Abstract] [Full Text] [Related]

  • 6. Specific inhibition of the classical complement pathway with an engineered single-chain Fv to C1q globular heads decreases complement activation by apoptotic cells.
    Duvall MR, Hwang HY, Boackle RJ.
    Immunobiology; 2010 May 01; 215(5):395-405. PubMed ID: 19586684
    [Abstract] [Full Text] [Related]

  • 7. Biochemical and functional characterization of the interaction between pentraxin 3 and C1q.
    Nauta AJ, Bottazzi B, Mantovani A, Salvatori G, Kishore U, Schwaeble WJ, Gingras AR, Tzima S, Vivanco F, Egido J, Tijsma O, Hack EC, Daha MR, Roos A.
    Eur J Immunol; 2003 Feb 01; 33(2):465-73. PubMed ID: 12645945
    [Abstract] [Full Text] [Related]

  • 8. Structure and function of the long pentraxin PTX3 glycosidic moiety: fine-tuning of the interaction with C1q and complement activation.
    Inforzato A, Peri G, Doni A, Garlanda C, Mantovani A, Bastone A, Carpentieri A, Amoresano A, Pucci P, Roos A, Daha MR, Vincenti S, Gallo G, Carminati P, De Santis R, Salvatori G.
    Biochemistry; 2006 Sep 26; 45(38):11540-51. PubMed ID: 16981714
    [Abstract] [Full Text] [Related]

  • 9. Serum amyloid P component binds to histones and activates the classical complement pathway.
    Hicks PS, Saunero-Nava L, Du Clos TW, Mold C.
    J Immunol; 1992 Dec 01; 149(11):3689-94. PubMed ID: 1431140
    [Abstract] [Full Text] [Related]

  • 10. C-reactive protein in myocardial infarction binds to circulating microparticles but is not associated with complement activation.
    van der Zee PM, Biró E, Trouw LA, Ko Y, de Winter RJ, Hack CE, Sturk A, Nieuwland R.
    Clin Immunol; 2010 Jun 01; 135(3):490-5. PubMed ID: 20138585
    [Abstract] [Full Text] [Related]

  • 11. Binding of C-reactive protein to nucleated cells leads to complement activation without cytolysis.
    Berman S, Gewurz H, Mold C.
    J Immunol; 1986 Feb 15; 136(4):1354-9. PubMed ID: 3944459
    [Abstract] [Full Text] [Related]

  • 12. Probing the C1q-binding site on human C-reactive protein by site-directed mutagenesis.
    Agrawal A, Volanakis JE.
    J Immunol; 1994 Jun 01; 152(11):5404-10. PubMed ID: 8189060
    [Abstract] [Full Text] [Related]

  • 13. Complement C1q-target proteins recognition is inhibited by electric moment effectors.
    Roumenina L, Bureeva S, Kantardjiev A, Karlinsky D, Andia-Pravdivy JE, Sim R, Kaplun A, Popov M, Kishore U, Atanasov B.
    J Mol Recognit; 2007 Jun 01; 20(5):405-15. PubMed ID: 17929239
    [Abstract] [Full Text] [Related]

  • 14. Sphingomyelinases D induce direct association of C1q to the erythrocyte membrane causing complement mediated autologous haemolysis.
    Tambourgi DV, Pedrosa MF, de Andrade RM, Billington SJ, Griffiths M, van den Berg CW.
    Mol Immunol; 2007 Jan 01; 44(4):576-82. PubMed ID: 16540172
    [Abstract] [Full Text] [Related]

  • 15. Anti-C1q autoantibodies specific against the globular domain of the C1qB-chain from patient with lupus nephritis inhibit C1q binding to IgG and CRP.
    Radanova M, Vasilev V, Deliyska B, Kishore U, Ikonomov V, Ivanova D.
    Immunobiology; 2012 Jul 01; 217(7):684-91. PubMed ID: 22209113
    [Abstract] [Full Text] [Related]

  • 16. Native, amyloid fibrils and beta-oligomers of the C-terminal domain of human prion protein display differential activation of complement and bind C1q, factor H and C4b-binding protein directly.
    Sjöberg AP, Nyström S, Hammarström P, Blom AM.
    Mol Immunol; 2008 Jun 01; 45(11):3213-21. PubMed ID: 18406463
    [Abstract] [Full Text] [Related]

  • 17. Molecular basis of C-reactive protein binding and modulation of complement activation by factor H-related protein 4.
    Hebecker M, Okemefuna AI, Perkins SJ, Mihlan M, Huber-Lang M, Józsi M.
    Mol Immunol; 2010 Mar 01; 47(6):1347-55. PubMed ID: 20042240
    [Abstract] [Full Text] [Related]

  • 18. Pathogenic implications for autoantibodies against C-reactive protein and other acute phase proteins.
    Sjöwall C, Wetterö J.
    Clin Chim Acta; 2007 Mar 01; 378(1-2):13-23. PubMed ID: 17239838
    [Abstract] [Full Text] [Related]

  • 19. Monomeric C-reactive protein modulates classic complement activation on necrotic cells.
    Mihlan M, Blom AM, Kupreishvili K, Lauer N, Stelzner K, Bergström F, Niessen HW, Zipfel PF.
    FASEB J; 2011 Dec 01; 25(12):4198-210. PubMed ID: 21856781
    [Abstract] [Full Text] [Related]

  • 20. New insights into the molecular mechanisms of classical complement activation.
    Kojouharova M, Reid K, Gadjeva M.
    Mol Immunol; 2010 Aug 01; 47(13):2154-60. PubMed ID: 20542571
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.